Related Experiment Video
Updated: Aug 25, 2026

Field Identification of Matricaria chamomilla using a Portable qPCR System
Published on: October 10, 2020
Herbal Creams in Dermatology: Efficacy, Safety, Formulation, and Regulatory Considerations
Raj Kamal1, Abhishek Chauhan1, Thakur Gurjeet Singh1
1Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
Abstract:
Herbal creams have gained significant prominence in dermatology for their safety, sustainability, and biologically active alternatives to conventional chemical-based formulations. Composed of plant-derived bioactive compounds, these preparations exhibit diverse pharmacological properties, including antiinflammatory, antimicrobial, antioxidant, and wound-healing effects. Key botanicals such as Aloe vera, turmeric, chamomile, tea tree oil, calendula, and liquorice contribute to the management of various skin disorders, including eczema, psoriasis, acne, and chronic wounds. Incorporation of advanced formulation strategies such as liposomes, nanoemulsions, and nanostructured lipid carriers has further enhanced dermal penetration, bioavailability, and therapeutic outcomes of herbal actives. Despite these advancements, concerns persist regarding the stability, purity, and safety of herbal creams, as natural origin alone does not guarantee the absence of adverse effects or contamination. Regulatory inconsistencies across global markets further complicate quality assurance, emphasising the need for harmonised guidelines encompassing Good Manufacturing Practices (GMP), Good Agricultural and Collection Practices (GACP), and advanced analytical validation. Sustainable sourcing, scientific standardisation, and clinical substantiation are essential to ensure reproducibility and consumer safety. The convergence of phytochemistry, nanotechnology, and regulatory science is poised to establish herbal creams as effective, evidence-based therapeutic options in modern dermatological practice.
Related Concept Videos
Drug Regulation
Clinically Relevant Drug Product Specifications: Methods of Establishment
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Preclinical Development: Overview
Clinical Applications of Epidermal Stem Cells
Bioequivalence: Overview